Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Small. 2008 Nov;4(11):2043–2050. doi: 10.1002/smll.200701275

Figure 4.

Figure 4

Cell viabilities determined by MTT assay of ovarian A2780 wild-type carcinoma cells treated with (a) micelles with folate: free DOX (white), DOX/PHIM-f (gray), and DOX/m-PHSM(20%)-f (dark gray), (b) micelles without folate: free DOX (white), DOX/PHIM (gray), and DOX/m-PHSM(20%) (dark gray). DOX dose was equivalent to 1000 ng/mL in each formulation.